The identification of dysfunctional crosstalk of pathways in Parkinson disease

Gene

Volumn 515, Issue 1, 2013, Pages 159-162

  Diao, Hongyu ^a   Li, Xinxing ^a   Hu, Sheng ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Department of Neurosurgery   (China)

Author keywords

Differentially expressed genes; Parkinson disease; Pathway crosstalk

Indexed keywords

BARRIER TO AUTOINTEGRATION FACTOR; BARRIER TO AUTOINTEGRATION FACTOR 1; BMI1 PROTEIN; BTG3 ASSOCIATED NUCLEAR PROTEIN; COILED COIL DOMAIN CONTAINING 101; COREPRESSOR PROTEIN; CXXC FINGER PROTEIN 1; FAMILY WITH SEQUENCE SIMILARITY 126 MEMBER A; GROWTH ARREST SPECIFIC 1 PROTEIN; LIGAND DEPENDENT NUCLEAR RECEPTOR COREPRESSOR; MEMBRANE PROTEIN; MERLIN; NINEIN; NUCLEAR PROTEIN; PEPTIDASE; PHOSPHOLIPASE; PHOSPHOLIPASE B DOMAIN CONTAINING 2 PROTEIN; PROTEIN; REGULATOR OF CHROMOSOME CONDENSATION 2 PROTEIN; RNA BINDING MOTIF PROTEIN 3; RNA BINDING PROTEIN; SPLICING FACTOR 3B SUBUNIT 2; STROMAL ANTIGEN 3 OPPOSITE STRAND PROTEIN; TRANSMEMBRANE PROTEIN 222; TUBULIN TYROSINE LIGASE LIKE FAMILY MEMBER 11 PROTEIN; UBIQUITIN SPECIFIC PEPTIDASE 21; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 281;

ARTICLE; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MOLECULAR INTERACTION; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TISSUE MICROARRAY; UPREGULATION;

FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MALE; PARKINSON DISEASE; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TRANSCRIPTOME;

EID: 84872273010     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.11.003     Document Type: Article

References (38)

1. Alibes A., Yankilevich P., Canada A., Diaz-Uriarte R. ID converter and ID Clight: conversion and annotation of gene and protein IDs. Bioinformatics 2007, 8:9.
2. Al-Shahrour F., Diaz-Uriarte R., Dopazo J. FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 2004, 20:578-580.
3. Benjamini Y.H. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 1995, 57:289-300.
4. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
5. Carlsson A. Thirty years of dopamine research. Adv. Neurol. 1993, 60:1-10.
6. Chartier-Harlin M.C., et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004, 364:1167-1169.
7. Chung K.K., et al. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med. 2001, 7:1144-1150.
8. Clayton D.F., George J.M. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 1998, 21:249-254.
9. Cooke S.F., Bliss T.V. Plasticity in the human central nervous system. Brain 2006, 129:1659-1673.
10. Cookson M.R. alpha-Synuclein and neuronal cell death. Mol. Neurodegener. 2009, 4:9.
11. Costa C., et al. Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. Brain 2012, 135:1884-1899.
12. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5:525-535.
13. Dodson M.W., Guo M. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr. Opin. Neurobiol. 2007, 17:331-337.
14. Esposito G., Ana Clara F., Verstreken P. Synaptic vesicle trafficking and Parkinson's disease. Dev. Neurobiol. 2012, 72:134-144.
15. Fischer von Mollard G., et al. Localization of Rab5 to synaptic vesicles identifies endosomal intermediate in synaptic vesicle recycling pathway. Eur. J. Cell Biol. 1994, 65:319-326.
16. Gautier L., Cope L., Bolstad B.M., Irizarry R.A. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20:307-315.
17. Goldman-Rakic P.S. The cortical dopamine system: role in memory and cognition. Adv. Pharmacol. 1998, 42:707-711.
18. Ideker T., Sharan R. Protein networks in disease. Genome Res. 2008, 18:644-652.
19. Irizarry R.A., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
20. Kanehisa M. The KEGG database. Novartis Found. Symp. 2002, 247:91-101. (discussion 101-103, 119-128, 244-152).
21. Kerr J.N., Wickens J.R. Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro. J. Neurophysiol. 2001, 85:117-124.
22. Kitada T., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
23. Langston J.W. The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann. Neurol. 2006, 59:591-596.
24. Lesage S., Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 2009, 18:R48-R59.
25. Lesnick T.G., et al. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet. 2007, 3:e98.
26. Nichols W.C., et al. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology 2009, 72:310-316.
27. Nuytemans K., Theuns J., Cruts M., Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum. Mutat. 2010, 31:763-780.
28. Shadrina M.I., Slominsky P.A., Limborska S.A. Molecular mechanisms of pathogenesis of Parkinson's disease. Int. Rev. Cell Mol. Biol. 2010, 281:229-266.
29. Singleton A.B., et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
30. Siuta M.A., et al. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol. 2010, 8:e1000393.
31. Storey J.D., Tibshirani R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9440-9445.
32. Subramanian A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15545-15550.
33. Tan E.K., et al. Analysis of the UCHL1 genetic variant in Parkinson's disease among Chinese. Neurobiol. Aging 2010, 31:2194-2196.
34. Team R.D.C. R: A Language and Environment for Statistical Computing 2011, R. Foundation for Statistical Computing.
35. Van Den Eeden S.K., et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am. J. Epidemiol. 2003, 157:1015-1022.
36. Wakabayashi K., Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur. Neurol. 1997, 38(Suppl. 2):2-7.
37. Wucherpfennig T., Wilsch-Brauninger M., Gonzalez-Gaitan M. Role of Drosophila Rab5 during endosomal trafficking at the synapse and evoked neurotransmitter release. J. Cell Biol. 2003, 161:609-624.
38. Zhao X.M., Wang R.S., Chen L., Aihara K. Uncovering signal transduction networks from high-throughput data by integer linear programming. Nucleic Acids Res. 2008, 36:e48.